However, the inhibition of NADPH oxidase did not significantly alter neutrophil‐mediated lung cancer death and instead increased their cytotoxicity, indicating that ROS production by neutrophils is not required for the anti‐cancer outcome they had observed. This evidence concerns the gene FMO5 and cancer.